Walleye Trading LLC Alnylam Pharmaceuticals, Inc. Transaction History

Walleye Trading LLC

  • $46.7 Billion
  • Q3 2024

A detailed history of Walleye Trading LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Walleye Trading LLC holds 6,600 shares of ALNY stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,600
Previous 4,000 65.0%
Holding current value
$1.56 Million
Previous $972,000 86.73%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$143.31 - $247.0 $3.42 Million - $5.89 Million
-23,854 Reduced 94.76%
1,318 $320,000
Q1 2024

May 15, 2024
BUY
$146.51 - $198.2 $389,863 - $527,410
2,661 Added 11.82%
25,172 $3.76 Million
Q4 2023

Feb 14, 2024
BUY
$151.41 - $196.57 $3.41 Million - $4.42 Million
22,511 New
22,511 $4.31 Million
Q2 2023

Aug 14, 2023
SELL
$185.01 - $212.05 $286,395 - $328,253
-1,548 Reduced 25.64%
4,489 $852,000
Q1 2023

May 15, 2023
BUY
$182.66 - $235.53 $1.1 Million - $1.42 Million
6,037 New
6,037 $1.21 Million
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $2.24 Million - $3.75 Million
16,154 Added 133.85%
28,223 $5.65 Million
Q2 2022

Aug 08, 2022
BUY
$120.42 - $169.29 $1.06 Million - $1.48 Million
8,764 Added 265.17%
12,069 $1.76 Million
Q4 2021

Feb 14, 2022
BUY
$159.56 - $209.29 $272,049 - $356,839
1,705 Added 106.56%
3,305 $560,000
Q3 2021

Nov 15, 2021
SELL
$169.75 - $207.73 $110,507 - $135,232
-651 Reduced 28.92%
1,600 $302,000
Q2 2021

Aug 16, 2021
BUY
$128.63 - $176.89 $205,422 - $282,493
1,597 Added 244.19%
2,251 $382,000
Q1 2021

May 17, 2021
SELL
$126.83 - $175.69 $97,024 - $134,402
-765 Reduced 53.91%
654 $92,000
Q4 2020

Feb 16, 2021
SELL
$122.97 - $147.0 $1.18 Million - $1.42 Million
-9,629 Reduced 87.16%
1,419 $184,000
Q1 2020

May 15, 2020
BUY
$93.12 - $133.99 $750,733 - $1.08 Million
8,062 Added 269.99%
11,048 $1.2 Million
Q3 2019

Nov 14, 2019
SELL
$70.9 - $87.82 $2,410 - $2,985
-34 Reduced 1.13%
2,986 $240,000
Q2 2019

Aug 14, 2019
SELL
$65.86 - $92.79 $145,945 - $205,622
-2,216 Reduced 42.32%
3,020 $219,000
Q4 2018

Feb 14, 2019
SELL
$62.67 - $88.33 $248,611 - $350,405
-3,967 Reduced 43.11%
5,236 $382,000
Q3 2018

Nov 14, 2018
BUY
$87.52 - $122.67 $401,629 - $562,932
4,589 Added 99.46%
9,203 $805,000
Q2 2018

Aug 14, 2018
BUY
$88.31 - $107.8 $407,462 - $497,389
4,614 New
4,614 $454,000

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email